Terbinafine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
An allylamine antifungal that is the treatment of choice for dermatophyte infections (onychomycosis, tinea capitis). Highly effective against Trichophyton, Microsporum, and Epidermophyton species. Oral terbinafine is the most effective treatment for toenail onychomycosis with cure rates of 70-80%. Also available topically for tinea pedis, tinea corporis, and tinea cruris.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
An allylamine antifungal that is the treatment of choice for dermatophyte infections (onychomycosis, tinea capitis). NutriStack rates the supporting evidence as strong. Common adult dosing is 250 mg once daily; toenail onychomycosis: 12 weeks; fingernail onychomycosis: 6 weeks; tinea capitis: 4-6 weeks (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: first-line treatment for toenail onychomycosis, treats fingernail onychomycosis, treats tinea capitis (oral). 10 sources indexed (2011–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Inhibits squalene epoxidase, a key enzyme in the fungal ergosterol biosynthetic pathway. This enzyme converts squalene to squalene-2,3-epoxide, an early step in ergosterol synthesis. Inhibition leads to squalene accumulation (which is directly toxic to fungal cells) and ergosterol depletion (which destabilizes the cell membrane). The dual mechanism makes terbinafine fungicidal against dermatophytes, unlike azoles which are primarily fungistatic.
Dosing & protocol.
Well absorbed orally (>70% bioavailability). Food slightly increases absorption but not clinically significant. Highly lipophilic, concentrates in skin, nails, and adipose tissue. Persists in nail tissue for months after discontinuation.
Full safety detail.
Side effects
- Headache
- Diarrhea
- Dyspepsia and abdominal pain
- Taste disturbance or loss (dysgeusia/ageusia)
- Elevated liver enzymes (hepatotoxicity, including rare liver failure)
- Skin rash
- Neutropenia (rare)
- Lupus-like reaction (very rare)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1A systematic review on the emergence of terbinafine-resistant Trichophyton indotineae in Europe: Time to act?PMIDFerreira CB, Lisboa C · Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
Ferreira CB, Lisboa C. A systematic review on the emergence of terbinafine-resistant Trichophyton indotineae in Europe: Time to act?. Journal of the European Academy of Dermatology and Venereology : JEADV. 2025
- 2Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic ReviewPMIDJegathees T, Holmes ZP, Martin C et al. · The Australasian journal of dermatology · 2025
Jegathees T, Holmes ZP, Martin C et al.. Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic Review. The Australasian journal of dermatology. 2025
- 3Systematic review of severe acute liver injury caused by terbinafinePMIDYan J, Wang X, Chen S · International journal of clinical pharmacy · 2014
Yan J, Wang X, Chen S. Systematic review of severe acute liver injury caused by terbinafine. International journal of clinical pharmacy. 2014
- 4A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazolePMIDYin Z, Xu J, Luo D · The Journal of dermatological treatment · 2012
Yin Z, Xu J, Luo D. A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole. The Journal of dermatological treatment. 2012
- 5Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitisPMIDTey HL, Tan AS, Chan YC · Journal of the American Academy of Dermatology · 2011
Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. Journal of the American Academy of Dermatology. 2011
Reference material
5- 6Kreijkamp-Kaspers S et al. Oral antifungal medication for toenail onychomycosis. Cochrane Database Syst Rev. 2017.Source linkedPMID
- 7Gupta AK et al. Systematic review of oral treatments for dermatophyte toenail onychomycosis: an update. Br J Dermatol. 2020.Source linkedPMID
- 8Chang CH et al. Terbinafine-associated hepatic failure. J Hepatol. 2007.Source linkedPMID
- 9Ajit C, Suvannasankha A, Zaeri N et al.. Terbinafine-associated hepatotoxicity. The American journal of the medical sciences. 2003Source linkedPMID
- 10Terbinafine. 2006Source linkedPMID
Common questions.
Quick answers about Terbinafine, drawn from the data on this page.
What is Terbinafine?
An allylamine antifungal that is the treatment of choice for dermatophyte infections (onychomycosis, tinea capitis). Highly effective against Trichophyton, Microsporum, and Epidermophyton species. Oral terbinafine is the most effective treatment for toenail onychomycosis with cure rates of 70-80%. Also available topically for tinea pedis, tinea corporis, and tinea cruris.
What is Terbinafine used for?
Commonly cited benefits of Terbinafine include: First-line treatment for toenail onychomycosis; Treats fingernail onychomycosis; Treats tinea capitis (oral); High cure rates for dermatophyte infections (70-80%); Once-daily dosing for defined treatment courses. NutriStack rates the overall evidence as strong.
What is a typical dose of Terbinafine?
A typical adult dose of Terbinafine is 250 mg once daily; toenail onychomycosis: 12 weeks; fingernail onychomycosis: 6 weeks; tinea capitis: 4-6 weeks (as prescribed by your physician). The commonly recommended form is Oral tablets; also available as topical cream, gel, or spray. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Terbinafine?
Reported side effects include headache, diarrhea, dyspepsia and abdominal pain, taste disturbance or loss (dysgeusia/ageusia), elevated liver enzymes (hepatotoxicity, including rare liver failure), skin rash. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Terbinafine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Terbinafine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.